Sapient Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5M Sell
49,415
-3,848
-7% -$897K 0.16% 71
2026
Q1
$13M Sell
53,263
-6,134
-10% -$1.43M 0.2% 74
2025
Q4
$12.3M Buy
59,397
+1,613
+3% +$319K 0.17% 82
2025
Q3
$10.5M Buy
57,784
+2,594
+5% +$444K 0.16% 88
2025
Q2
$8.43M Sell
55,190
-4,090
-7% -$629K 0.15% 88
2025
Q1
$9.83M Sell
59,280
-690
-1% -$108K 0.19% 79
2024
Q4
$8.67M Sell
59,970
-160
-0.3% -$24.8K 0.17% 87
2024
Q3
$9.74M Sell
60,130
-1,597
-3% -$254K 0.2% 77
2024
Q2
$9.02M Sell
61,727
-1,523
-2% -$227K 0.19% 77
2024
Q1
$10M Buy
63,250
+6,374
+11% +$1.01M 0.22% 76
2023
Q4
$8.91M Buy
+56,876
New +$8.72M 0.23% 75

Other funds holding JNJ

Sapient Capital's JNJ Position: Q2 2026 in Review

Sapient Capital reduced its Johnson & Johnson (JNJ) stake by 7.2% in Q2 2026, selling an estimated $897K and leaving 49,415 shares worth $12.5M. The position accounts for 0.16% of the portfolio, ranked #71.

Sapient Capital first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $13M in Q1 2026. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sapient Capital held 49,415 shares of Johnson & Johnson worth $12.5M as of Q2 2026.
  • Sapient Capital sold 3,848 Johnson & Johnson shares in Q2 2026, an estimated $897K.
  • Johnson & Johnson made up 0.16% of Sapient Capital's portfolio in Q2 2026, its #71 holding.
  • Sapient Capital first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's Johnson & Johnson position peaked at $13M in Q1 2026.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.